FDA reveals AstraZeneca Have applied for COVID 19 vaccine registration in Thailand. The Director-General of the Department of Disease Control revealed that the FDA will allow emergency vaccinations this week.
January 18, 2021 Thai News Agency Reported that Dr. Opasakarn Kawinpong Director-General, Department of Disease Control Discuss the progress of vaccine registration.COVID 19 Know that the FDA will allow emergency vaccinations this week. Which will be in line with the vaccination beginning in late February But the details are requested to wait for the FDA.
–
Dr. Opas said that in the vaccinationCOVID-19 Adverse reactions will be followed up up to 4 weeks after the vaccination, with the effects they may or may not have. Or risk There must be an expert committee to consider this matter. If death is required, an autopsy is required. However, vaccination is voluntary. There are currently some surveys. The vaccine to be administered is not related to the affected vaccine. Or there are many side effects that are some of the most criticized We did not order Not registered in Thailand.
–
–
While Dr. Surachok Tangwiwat, Deputy Secretary-General of the FDA, said that the company Astra Seneca Vaccine manufacturer COVID-19 In foreign countries, documents for vaccine registration have been submitted in Thailand with the FDA, with a declaration of production quality, production process. To be able to be sold in Thailand Once passed, it will speed up the registration of AstraZeneca vaccines in Thailand.The vaccine is unrelated to 26 million doses of vaccines made in Thailand.
–
–
Thanks to information from
–
–
–
:quality(80)/cdn-kiosk-api.telegraaf.nl/6bd124b6-59a6-11eb-9725-0218eaf05005.jpg?resize=150%2C150&ssl=1)